U.S. Medicare, Medicaid, CMMI, 340B, commercial payers, PBMs, specialty pharmacies, health systems, and wholesalers and distributers

EMA, EUC, and European Market Access

Asia, Middle East, Eastern Europe, Canada, and Latin America Market Access

Low-and-Middle Income countries (LMIC)

Access to Medicines Index (ATMI) Reporting and Strategy

Organizational structure and integration optimization

VAP and HEOR capability assessment and gap analysis

Efficiency and productivity assessment, reporting and improvement

Transformation, and innovation and change management

Principles of Effective Leadership

Personnel management

Professional executive mentoring

Staff development and Career Ladders

Strategic Planning including trend analysis, vision and mission statements, and objective planning

VAP, HEOR, and sales force management

Organizational Health

Risk Management

Horizon scanning

End-to-end product lifecycle solutions

Business Development and due diligence evaluations

Asset value assessment and risk analyses

Long Term Financial Planning (LTFP) and Forecasting

Architype modeling

Pipeline strategy and prioritization

Early access input

Market access and pricing study design optimization

Market Access Launch Planning

Brand and Access Strategies

Launch pricing and management

Payer Objection Handlers

Value Story and messaging

Mock negotiation training

Cost Effectiveness Assessment and Managed Entry Agreements

Global Value Dossier preparation and submission

Pricing Analytics

New drug pricing

Pricing governance and Grants of Authority

Innovative and value-based contracting

Managed Entry Agreements (MEA)

Strategic agency and payer negotiation

340B pricing

Patient Assistance Programing

Government Price Reporting

Health policy trend analysis and insights

Policy simulation, modeling, and impact analysis

Legislative policy development and writing

Legislative vehicle identification

Lobbying strategy and planning

Coding and reimbursement policy analysis

Clinical Trial and Real-World Evidence generation

Health Technology Assessment (HTA) and dossier preparation and submission

Advanced Economic and Predictive Modeling

Patient Reported Outcomes (PRO) design and assessment

Statistical and Meta analysis

Novel endpoint validation

Product differentiation

Value creation and patient value frameworks

Health Equity assessment and research

Industry applications of RWD

RWD needs assessment, data framework prioritization, and sourcing

HTA evidentiary standards frameworks and landscaping

Validated real world data analysis

Regulatory, HTA, and payer submission

Biomedical informatics

VAP & HEOR application of artificial intelligence (AI)